Ameriprise’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,512
Closed -$421K 4126
2024
Q3
$421K Sell
15,512
-105
-0.7% -$3.18K ﹤0.01% 3544
2024
Q2
$449K Sell
15,617
-3,798
-20% -$116K ﹤0.01% 3453
2024
Q1
$566K Sell
19,415
-1,392
-7% -$38.9K ﹤0.01% 3375
2023
Q4
$676K Sell
20,807
-3,805
-15% -$110K ﹤0.01% 3344
2023
Q3
$788K Sell
24,612
-389
-2% -$15K ﹤0.01% 3242
2023
Q2
$1.1M Buy
25,001
+971
+4% +$44.8K ﹤0.01% 3129
2023
Q1
$1.06M Sell
24,030
-56,980
-70% -$2.52M ﹤0.01% 3119
2022
Q4
$3.22M Sell
81,010
-16,308
-17% -$679K ﹤0.01% 2564
2022
Q3
$4.49M Sell
97,318
-6,146
-6% -$301K ﹤0.01% 2299
2022
Q2
$4.46M Buy
103,464
+6,866
+7% +$314K ﹤0.01% 2369
2022
Q1
$5.22M Sell
96,598
-6
-0% -$307 ﹤0.01% 2395
2021
Q4
$5.78M Buy
96,604
+21,968
+29% +$1.37M ﹤0.01% 2371
2021
Q3
$4.89M Sell
74,636
-186
-0.2% -$12.1K ﹤0.01% 2404
2021
Q2
$4.73M Sell
74,822
-4,020
-5% -$231K ﹤0.01% 2492
2021
Q1
$3.84M Buy
78,842
+6,748
+9% +$324K ﹤0.01% 2549
2020
Q4
$2.97M Buy
72,094
+8,522
+13% +$391K ﹤0.01% 2598
2020
Q3
$2.92M Buy
63,572
+7,676
+14% +$356K ﹤0.01% 2446
2020
Q2
$2.44M Buy
55,896
+18,779
+51% +$845K ﹤0.01% 2504
2020
Q1
$1.47M Buy
37,117
+497
+1% +$22.3K ﹤0.01% 2637
2019
Q4
$1.72M Buy
36,620
+695
+2% +$26.9K ﹤0.01% 2808
2019
Q3
$1.27M Buy
35,925
+13,115
+57% +$454K ﹤0.01% 2916
2019
Q2
$889K Buy
22,810
+3,900
+21% +$157K ﹤0.01% 3113
2019
Q1
$837K Buy
+18,910
New +$719K ﹤0.01% 3105

Other funds holding KIDS

Ameriprise's KIDS Position: Q4 2024 in Review

Ameriprise sold out of OrthoPediatrics (KIDS) in Q4 2024, closing a stake of 15,512 shares — an estimated $421K sold.

Ameriprise first reported a position in KIDS in Q1 2019 and held it in 23 quarters. The position peaked at $5.78M in Q4 2021. 108 funds tracked by Wall St. Rank hold KIDS as of Q4 2024.

  • Ameriprise reported no remaining OrthoPediatrics position as of Q4 2024 after selling out during the quarter.
  • Ameriprise sold 15,512 OrthoPediatrics shares in Q4 2024, an estimated $421K.
  • Ameriprise first reported a position in OrthoPediatrics in Q1 2019 and held it in 23 quarters.
  • Ameriprise's OrthoPediatrics position peaked at $5.78M in Q4 2021.
  • 108 funds tracked by Wall St. Rank held OrthoPediatrics as of Q4 2024.

Based on Ameriprise's 13F filing for Q4 2024, filed 14 Feb 2025.